Expectations trend
FY2028 · fiscal year ending 2028-06-30 · fmp
Upexi Inc (UPXI)
NASDAQCommunication ServicesInternet Content & InformationSnapshot 2026-11-05
$0.66-14.04%
Close 2026-11-05 · 1-day change
NASDAQCommunication ServicesInternet Content & InformationSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.02 → 0.02 EPS · FY ending Jun 30, 2028 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for UPXI yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Reduce net losses from -$109M | A supporting condition in Upexi Inc's published investment case. The stated target is Net loss less negative than -$109 million. | Broken | Net loss worsens beyond -$109 million | Net income: $-24.544M FY2026-Q4; GAAP. Published target: Net loss less negative than -$109 million. The stored target says 2026-Q3; this source reports FY2026-Q4. Fiscal/calendar alignment needs review. Sep 17, 2026-24,544,060 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-06-30 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative, loss-making business with a volatile management record and weak recent financial performance. The long-term thesis is on watch: recent momentum measures improved, but the company still faces high risk and its performance trails its industry cohort.
UPXI is flagged as expensive versus peers, with a durable premium despite weak execution quality. The expectations gap is elevated, but valuation-model confidence is low, so the evidence for what the market assumes is limited.
Near term, earnings risk is elevated, with a 55% estimated miss probability, and guidance cuts would be a meaningful setback. Cost reductions and higher gross profit show partial progress, but operating income remains deeply negative, partly due to unrealized digital asset losses. Management is also pursuing a Solana-focused digital asset treasury strategy, whose contribution remains uncertain.
Over the next few quarters, the thesis hinges on whether cost reductions and staking revenue improve cash flow without further weakening execution. A guidance cut would add pressure, while Fed rate cuts or continued strong results from sector bellwethers could support the sector backdrop. Evidence on the digital asset strategy and the recent M&A activity is thin.
Over the next 1 to 3 years, UPXI remains a high-risk, loss-making story with some operational progress but no clear proof yet of durable profitability. The thesis depends on better cash flow and execution narrowing the gap between its premium valuation and weak fundamentals. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 1 of 2 supplied quarters. Management reported: “We also completed our efficiency initiative, and expect staking revenue to exceed ongoing cash operating expenses beginning with the current quarter.” “· Reduced ongoing operational costs, including the reduction of the employee count to 10 employees, the elimination of a warehouse lease and the elimination of several other general and administrative costs.”
Reduce negative cash from operations below -$4.8M | Cash from operations improved from -$9.8M to -$4.8M in recent quarters. | Broken | Cash from operations falls below -$4.8 million | Cash from operations: $-3.718M FY2026-Q4; GAAP. Published target: Cash from operations better than -$4.8 million. The stored target says 2026-Q3; this source reports FY2026-Q4. Fiscal/calendar alignment needs review. Sep 17, 2026-3,717,677 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 2 supplied quarters. Management reported: “We also completed our efficiency initiative, and expect staking revenue to exceed ongoing cash operating expenses beginning with the current quarter.” “· Reduced ongoing operational costs, including the reduction of the employee count to 10 employees, the elimination of a warehouse lease and the elimination of several other general and administrative costs.” Delivery assessment Nov 5, 2026 |
Manage $36 million convertible promissory note | Upexi aims to manage $36M in convertible notes to support operations. | Improving | Convertible note management fails or debt burden increases materially | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve revenue growth near 29% next year | Revenue is expected to grow about 29% next year. | Recovered | Revenue growth falls below 20% next year | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Unavailable → $0.02 · observed estimates
$0.05B → $0.04B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-09-10 | Unavailable | $52,000,000 | 0 / 1 |
| 2026-09-11 | $0.02 | $52,000,000 | 1 / 1 |
| 2026-09-12 | $0.02 | $52,000,000 | 1 / 1 |
| 2026-09-13 | $0.02 | $52,000,000 | 1 / 1 |
| 2026-09-14 | $0.02 | $52,000,000 | 1 / 1 |
| 2026-09-15 | $0.02 | $52,000,000 | 1 / 1 |
| 2026-09-16 | $0.02 | $52,000,000 | 1 / 1 |
| 2026-09-17 | $0.02 | $52,000,000 | 1 / 1 |
| 2026-09-18 | $0.02 | $52,000,000 | 1 / 1 |
| 2026-09-19 | $0.02 | $52,000,000 | 1 / 1 |
| 2026-09-20 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-09-21 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-09-22 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-09-23 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-09-24 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-09-25 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-09-26 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-09-27 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-09-28 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-09-29 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-09-30 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-01 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-02 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-03 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-04 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-05 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-06 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-07 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-08 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-09 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-10 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-11 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-12 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-13 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-14 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-15 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-16 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-17 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-18 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-19 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-20 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-21 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-22 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-23 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-24 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-25 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-26 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-27 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-28 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-29 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-30 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-10-31 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-11-01 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-11-02 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-11-03 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-11-04 | $0.02 | $43,600,000 | 1 / 1 |
| 2026-11-05 | $0.02 | $43,600,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 10, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.